Dr. José Maximiliano Medina-Ramírez is a Postdoctoral Researcher on Vaccine Design at the Academic Medical Center (AMC) of the University of Amsterdam (The Netherlands). In 2012, he earned his PhD degree in microbiology for the Autonomous University of Nuevo Leon (Mexico) in partnership with the University of Barcelona (Spain). In 2012 he started his postdoctoral career at the AMC where he initiated a research line focused on the development of immunogens based on the human immunodeficiency virus (HIV) envelope glycoprotein trimer (Env) for use in vaccination strategies.

Dr. Medina-Ramírez has authored multiple publications, received several grants and since 2015 he has been presenting his work at international conferences on HIV vaccines. In 2017, he received the designation as inventor by the European Patent Office and his invention has received funding from the Bill & Melinda Gates Foundation to conduct a phase I clinical trial.

To date he continues at the AMC where he leads a team of scientists dedicated to the optimization of immunogens and immunization strategies as well as to the isolation and characterization of monoclonal antibodies.